The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of EML4-ALK fusion variant and co-occurring TP53 mutation on treatment duration of first-line next-generation ALK TKIs in ALK fusion+ NSCLC.
 
Kaushal Parikh
Consulting or Advisory Role - Guardant Health; Jazz Pharmaceuticals (Inst); MJH Life Sciences
Research Funding - Pfizer
 
Anastasios Dimou
Honoraria - Intellisphere; Intellisphere (Inst); Intellisphere (Inst); Roche/Genentech
Consulting or Advisory Role - Anheart Therapeutics; ChromaCode; Guardant Health (Inst); TP Therapeutics (Inst)
Research Funding - Anheart Therapeutics (Inst); Anheart Therapeutics (Inst); Guardant Health; Merck; Novartis (Inst); Sorrento Therapeutics (Inst); Sorrento Therapeutics (Inst); Syntrix Biosystems (Inst)
Travel, Accommodations, Expenses - Guardant Health
Other Relationship - Rising Tide Foundation (Inst)
 
Konstantinos Leventakos
Consulting or Advisory Role - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Janssen Oncology (Inst); Jazz Pharmaceuticals (Inst); Mirati Therapeutics (Inst); MJH Life Sciences (Inst); OncLive (Inst); Regeneron (Inst); Takeda (Inst); Targeted Oncology (Inst)
Research Funding - AstraZeneca (Inst); Mirati Therapeutics (Inst)
 
Yin Wan
Employment - Takeda
 
Huamao Mark Lin
Employment - Takeda
 
Sylvie Vincent
Employment - Takeda
 
Jennifer Elliott
Employment - Takeda
 
Ioana R Bonta
Consulting or Advisory Role - Bayer; Roche